Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$643M |
| 2 |
Boston Scientific
BSX
|
+$432M |
| 3 |
Eli Lilly
LLY
|
+$415M |
| 4 |
Apple
AAPL
|
+$347M |
| 5 |
Shopify
SHOP
|
+$346M |
Top Sells
| 1 |
Boeing
BA
|
+$682M |
| 2 |
Meta Platforms (Facebook)
META
|
+$569M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$527M |
| 4 |
American Tower
AMT
|
+$474M |
| 5 |
Workday
WDAY
|
+$350M |
Sector Composition
| 1 | Technology | 27.37% |
| 2 | Consumer Discretionary | 17.94% |
| 3 | Healthcare | 14.27% |
| 4 | Communication Services | 12.28% |
| 5 | Financials | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
251
DELISTED
Sage Therapeutics
SAGE
| $31.1M | 0.03% |
431,209
-2,412,480
| -85% | -$174M |
|
252
Varonis Systems
VRNS
$6.45B
| $31.1M | 0.03% |
1,201,554
-19,968
| -2% | -$517K |
|
253
Glaukos
GKOS
$5.27B
| $30.5M | 0.03% |
560,144
+233,373
| +71% | +$12.7M |
|
254
Cardlytics
CDLX
$48.5M
| $30.3M | 0.03% |
482,290
-220,431
| -31% | -$13.9M |
|
255
Bandwidth Inc
BAND
$473M
| $30.3M | 0.03% |
472,912
+61,066
| +15% | +$3.91M |
|
256
Tandem Diabetes Care
TNDM
$845M
| $30.1M | 0.03% |
+504,605
| New | +$30.1M |
|
257
Cintas
CTAS
$81.7B
| $30M | 0.03% |
446,428
-265,748
| -37% | -$17.9M |
|
258
Lamb Weston
LW
$8.02B
| $29.3M | 0.03% |
340,358
-199,572
| -37% | -$17.2M |
|
259
Adecoagro
AGRO
$803M
| $29M | 0.03% |
3,466,046
-21,062
| -0.6% | -$176K |
|
260
Independence Realty Trust
IRT
$4.18B
| $29M | 0.03% |
2,056,086
-36,371
| -2% | -$512K |
|
261
Wells Fargo
WFC
$254B
| $28.9M | 0.03% |
537,998
-115,552
| -18% | -$6.22M |
|
262
Alcon
ALC
$39.5B
| $28.9M | 0.03% |
511,058
+262,079
| +105% | +$14.8M |
|
263
AXIS Capital
AXS
$7.67B
| $28.1M | 0.03% |
473,343
+215,759
| +84% | +$12.8M |
|
|
B
264
Barrick Mining Corporation
B
$49.5B
| $28.1M | 0.03% |
1,512,755
-1,154,976
| -43% | -$21.5M |
|
265
Sea Limited
SE
$113B
| $27.8M | 0.03% |
690,635
+43,169
| +7% | +$1.74M |
|
266
Agilent Technologies
A
$36.3B
| $27.8M | 0.03% |
+325,579
| New | +$27.8M |
|
267
First Bancorp
FBNC
$2.3B
| $27.3M | 0.03% |
683,982
-11,788
| -2% | -$470K |
|
|
INN
268
Summit Hotel Properties
INN
$608M
| $27.1M | 0.03% |
2,193,279
+326,068
| +17% | +$4.02M |
|
269
IMAX
IMAX
$1.67B
| $26.9M | 0.03% |
1,315,418
+12
| +0% | +$245 |
|
270
ING
ING
$72.5B
| $26.8M | 0.03% |
+2,226,183
| New | +$26.8M |
|
271
Ingersoll Rand
IR
$31.9B
| $26.7M | 0.03% |
727,382
-600,202
| -45% | -$22M |
|
272
Plains All American Pipeline
PAA
$12.1B
| $26.7M | 0.03% |
1,449,419
-16,491
| -1% | -$303K |
|
273
Neurocrine Biosciences
NBIX
$14.3B
| $26.6M | 0.03% |
247,528
+14,547
| +6% | +$1.56M |
|
274
Agios Pharmaceuticals
AGIO
$2.12B
| $26.2M | 0.03% |
548,353
+4,749
| +0.9% | +$227K |
|
275
ProQR Therapeutics
PRQR
$245M
| $26.1M | 0.03% |
2,630,626
+11,614
| +0.4% | +$115K |
|